Tbx3 represses PTEN and is over-expressed in head and neck squamous cell carcinoma

[1]  R. Kramer,et al.  Transcriptional profiling identifies upregulated genes following induction of epithelial-mesenchymal transition in squamous carcinoma cells. , 2012, Experimental cell research.

[2]  J. Nör,et al.  The biology of head and neck cancer stem cells. , 2012, Oral oncology.

[3]  Roland L. Dunbrack,et al.  Protein-intrinsic and signaling network-based sources of resistance to EGFR- and ErbB family-targeted therapies in head and neck cancer. , 2011, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[4]  A. McKenna,et al.  The Mutational Landscape of Head and Neck Squamous Cell Carcinoma , 2011, Science.

[5]  R. Weinberg,et al.  A Perspective on Cancer Cell Metastasis , 2011, Science.

[6]  C. Goding,et al.  PMA-induced up-regulation of TBX3 is mediated by AP-1 and contributes to breast cancer cell migration. , 2011, The Biochemical journal.

[7]  E. Lander,et al.  Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling , 2010, Proceedings of the National Academy of Sciences.

[8]  L. Tanoue.  Cancer Statistics, 2009 , 2010 .

[9]  David J Weber,et al.  Deletion of PTEN promotes tumorigenic signaling, resistance to anoikis, and altered response to chemotherapeutic agents in human mammary epithelial cells. , 2009, Cancer research.

[10]  E. Golemis,et al.  Targeting EGFR resistance networks in head and neck cancer. , 2009, Cellular signalling.

[11]  Sabine Riethdorf,et al.  Review: Biological relevance of disseminated tumor cells in cancer patients , 2008, International journal of cancer.

[12]  L. Lanfrancone,et al.  Tbx3 represses E-cadherin expression and enhances melanoma invasiveness. , 2008, Cancer research.

[13]  J. Paramio,et al.  Akt pathway as a target for therapeutic intervention in HNSCC. , 2008, Histology and histopathology.

[14]  A. Moorman,et al.  TBX3 and its splice variant TBX3 + exon 2a are functionally similar , 2008, Pigment cell & melanoma research.

[15]  S A Forbes,et al.  The Catalogue of Somatic Mutations in Cancer (COSMIC) , 2008, Current protocols in human genetics.

[16]  S. Cetin,et al.  Expression of PTEN protein in patients with laryngeal squamous cell carcinoma. , 2007, Auris, nasus, larynx.

[17]  B. Bilican,et al.  T-box factors: targeting to chromatin and interaction with the histone H3 N-terminal tail. , 2007, Pigment cell research.

[18]  C. Eng,et al.  Comparative genomic and functional analyses reveal a novel cis-acting PTEN regulatory element as a highly conserved functional E-box motif deleted in Cowden syndrome. , 2007, Human molecular genetics.

[19]  S. Cairo,et al.  Tbx3 is a downstream target of the Wnt/beta-catenin pathway and a critical mediator of beta-catenin survival functions in liver cancer. , 2007, Cancer research.

[20]  F. E. Bertrand,et al.  CBF-1 (RBP-Jk) Binds to the PTEN Promoter and Regulates PTEN Gene Expression , 2007, Cell cycle.

[21]  T. Stokke,et al.  Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancer , 2006, BMC Genomics.

[22]  Ji Luo,et al.  The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism , 2006, Nature Reviews Genetics.

[23]  G. Su,et al.  A novel mutation of STK11/LKB1 gene leads to the loss of cell growth inhibition in head and neck squamous cell carcinoma , 2006, Oncogene.

[24]  Farin Kamangar,et al.  Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  U. Hellman,et al.  Increased expression of cSHMT, Tbx3 and utrophin in plasma of ovarian and breast cancer patients , 2006, International journal of cancer.

[26]  Cristina M. Pinto,et al.  Retracted: Frequent genetic and biochemical alterations of the PI 3‐K/AKT/PTEN pathway in head and neck squamous cell carcinoma , 2005, International journal of cancer.

[27]  A. Hui,et al.  Characterization of chromosome 3q and 12q amplicons in nasopharyngeal carcinoma cell lines. , 2005, International journal of oncology.

[28]  A. Maitra,et al.  Met Proto-Oncogene and Insulin-Like Growth Factor Binding Protein 3 Overexpression Correlates with Metastatic Ability in Well-Differentiated Pancreatic Endocrine Neoplasms , 2004, Clinical Cancer Research.

[29]  J. Gray,et al.  TBX3 and Its Isoform TBX3+2a Are Functionally Distinctive in Inhibition of Senescence and Are Overexpressed in a Subset of Breast Cancer Cell Lines , 2004, Cancer Research.

[30]  K. Vuori,et al.  Regulation of Bcl-2 proteins during anoikis and amorphosis. , 2004, Biochimica et biophysica acta.

[31]  F. Couch,et al.  The Role of Tbx2 and Tbx3 in Mammary Development and Tumorigenesis , 2004, Journal of Mammary Gland Biology and Neoplasia.

[32]  J. Herman,et al.  Gene silencing in cancer in association with promoter hypermethylation. , 2003, The New England journal of medicine.

[33]  Charis Eng,et al.  PTEN: One Gene, Many Syndromes , 2003, Human mutation.

[34]  Virginia E. Papaioannou,et al.  Mammary gland, limb and yolk sac defects in mice lacking Tbx3, the gene mutated in human ulnar mammary syndrome , 2003, Development.

[35]  J. Grandis,et al.  The role of epidermal growth factor receptor in head and neck squamous cell carcinoma , 2003, Current oncology reports.

[36]  Diane D. Liu,et al.  Cyclin D1 genotype, response to biochemoprevention, and progression rate to upper aerodigestive tract cancer. , 2003, Journal of the National Cancer Institute.

[37]  T. Dreyer,et al.  Genomic gain of PIK3CA and increased expression of p110alpha are associated with progression of dysplasia into invasive squamous cell carcinoma , 2002, The Journal of pathology.

[38]  M. van Lohuizen,et al.  The T-box Repressors TBX2 and TBX3Specifically Regulate the Tumor Suppressor Genep14 ARF via a Variant T-site in the Initiator* , 2002, The Journal of Biological Chemistry.

[39]  K. Kelsey,et al.  Patterns of gene promoter methylation in squamous cell cancer of the head and neck , 2002, Oncogene.

[40]  P. Hurlin,et al.  Tbx3 impinges on the p53 pathway to suppress apoptosis, facilitate cell transformation and block myogenic differentiation , 2002, Oncogene.

[41]  S. Nomoto,et al.  ΔNp63 induces β-catenin nuclear accumulation and signaling , 2002 .

[42]  T. Liu,et al.  Promoter analysis of tumor suppressor gene PTEN: identification of minimum promoter region. , 2002, Biochemical and biophysical research communications.

[43]  M. MacDonald,et al.  TBX-3, the Gene Mutated in Ulnar-Mammary Syndrome, Is a Negative Regulator of p19 ARF and Inhibits Senescence* , 2002, The Journal of Biological Chemistry.

[44]  S. Nomoto,et al.  DeltaNp63 induces beta-catenin nuclear accumulation and signaling. , 2002, Cancer cell.

[45]  M. Poetsch,et al.  Detection of new PTEN/MMAC1 mutations in head and neck squamous cell carcinomas with loss of chromosome 10. , 2002, Cancer genetics and cytogenetics.

[46]  T. Mustelin,et al.  The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling , 2001, Nature Cell Biology.

[47]  W. Hong,et al.  Loss of PTEN expression as a prognostic marker for tongue cancer. , 2001, Archives of otolaryngology--head & neck surgery.

[48]  P. Hurlin,et al.  A dominant repression domain in Tbx3 mediates transcriptional repression and cell immortalization: relevance to mutations in Tbx3 that cause ulnar-mammary syndrome. , 2001, Human molecular genetics.

[49]  T. Mak,et al.  Regulation of PTEN transcription by p53. , 2001, Molecular cell.

[50]  Ryozo Nagai,et al.  Tbx5 associates with Nkx2-5 and synergistically promotes cardiomyocyte differentiation , 2001, Nature Genetics.

[51]  Kenneth M. Yamada,et al.  Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis. , 2001, Journal of cell science.

[52]  J. Drouin,et al.  A Pituitary Cell-Restricted T Box Factor, Tpit, Activates POMC Transcription in Cooperation with Pitx Homeoproteins , 2001, Cell.

[53]  J. Smith,et al.  T‐targets: Clues to understanding the functions of T‐box proteins , 2001, Development, growth & differentiation.

[54]  Leila Mohammadi,et al.  BMC Cancer , 2001 .

[55]  Y. Rao,et al.  Erratum: Transcription repression by Xenopus ET and its human ortholog TBX3, a gene involved in ulnar-mammary syndrome (Proceedings of the National Academy of Sciences of the United States of America (August 31, 1999) 96:18 (10212-10217)) , 1999 .

[56]  Y. Rao,et al.  Transcription repression by Xenopus ET and its human ortholog TBX3, a gene involved in ulnar-mammary syndrome. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[57]  J. Seidman,et al.  The spectrum of mutations in TBX3: Genotype/Phenotype relationship in ulnar-mammary syndrome. , 1999, American journal of human genetics.

[58]  José Luis de la Pompa,et al.  Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTEN , 1998, Cell.

[59]  C. R. Goding,et al.  Brachyury-Related Transcription Factor Tbx2 and Repression of the Melanocyte-Specific TRP-1 Promoter , 1998, Molecular and Cellular Biology.

[60]  L. Silver,et al.  The T‐box gene family , 1998, BioEssays : news and reviews in molecular, cellular and developmental biology.

[61]  I. Fleming,et al.  The national cancer data base report on recent hospital cancer program progress toward complete American joint committee on cancer/TNM staging , 1997, Cancer.

[62]  C. Müller,et al.  Crystallographic structure of the T domain–DNA complex of the Brachyury transcription factor , 1997, Nature.

[63]  L. Silver,et al.  Evolution of mouse T-box genes by tandem duplication and cluster dispersion. , 1996, Genetics.

[64]  R H Hruban,et al.  Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. , 1995, The New England journal of medicine.

[65]  N. Dracopoli,et al.  Current protocols in human genetics , 1994 .

[66]  B. Herrmann,et al.  The Brachyury gene encodes a novel DNA binding protein. , 1993, The EMBO journal.

[67]  Mohamad Maghniea,et al.  The Pituitary , 1919, The Indian Medical Gazette.